首页> 美国卫生研究院文献>Alzheimers Research Therapy >Pooled-DNA sequencing identifies novel causative variants in PSEN1 GRN and MAPT in a clinical early-onset and familial Alzheimers disease Ibero-American cohort
【2h】

Pooled-DNA sequencing identifies novel causative variants in PSEN1 GRN and MAPT in a clinical early-onset and familial Alzheimers disease Ibero-American cohort

机译:合并的DNA测序可在临床早发和家族性阿尔茨海默氏病伊比利亚美洲队列中识别PSEN1GRN和MAPT中的新致病性变异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionSome familial Alzheimer's disease (AD) cases are caused by rare and highly-penetrant mutations in APP, PSEN1, and PSEN2. Mutations in GRN and MAPT, two genes associated with frontotemporal dementia (FTD), have been found in clinically diagnosed AD cases. Due to the dramatic developments in next-generation sequencing (NGS), high-throughput sequencing of targeted genomic regions of the human genome in many individuals in a single run is now cheap and feasible. Recent findings favor the rare variant-common disease hypothesis by which the combination effects of rare variants could explain a large proportion of the heritability. We utilized NGS to identify rare and pathogenic variants in APP, PSEN1, PSEN2, GRN, and MAPT in an Ibero-American cohort.
机译:简介某些家族性阿尔茨海默氏病(AD)病例是由APP,PSEN1和PSEN2中的罕见且高度穿透的突变引起的。在临床确诊的AD病例中发现了与额颞叶痴呆(FTD)相关的两个基因GRN和MAPT的突变。由于下一代测序(NGS)的迅猛发展,单次运行中许多个体中人类基因组靶向基因组区域的高通量测序现已变得便宜且可行。最近的发现支持稀有变异-常见疾病假说,通过该假说,稀有变异的组合效应可以解释遗传力的很大一部分。我们利用NGS鉴定了伊比利亚美洲队列中APP,PSEN1,PSEN2,GRN和MAPT中的罕见病原体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号